SuperworthOramed Pharmaceuticals shares outstanding ORMP
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 42.5M
- On a year earlier
- −0.3%
- fewer shares
Oramed Pharmaceuticals had 42.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 40.8M | +0% |
| FY2024 | 40.8M | −0% |
| FY2023 | 40.8M | +3% |
| FY2022 | 39.4M | +19% |
| FY2021 | 33.1M | +40% |
| FY2020 | 23.6M | +35% |
| FY2019 | 17.5M | +7% |
| FY2018 | 16.3M | +21% |
| FY2017 | 13.4M | +2% |
| FY2016 | 13.1M | +14% |
| FY2015 | 11.5M | +15% |
| FY2014 | 10M | +32% |
| FY2013 | 7.6M | +26% |
| FY2012 | 6M | +2% |
| FY2011 | 5.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 42.5M | −0% | |
| Q1 FY26 | 42M | +2% | |
| Q4 FY25 | 40.8M | +0% | |
| Q3 FY25 | 42.8M | +5% | |
| Q2 FY25 | 42.6M | +2% | |
| Q1 FY25 | 41.2M | −1% | |
| Q4 FY24 | 40.8M | −0% | |
| Q3 FY24 | 40.9M | +1% | |
| Q2 FY24 | 41.6M | +3% | |
| Q1 FY24 | 41.6M | +4% | |
| Q4 FY23 | 40.8M | +3% | |
| Q3 FY23 | 40.4M | +3% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Oramed Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.